MapfreMPFRF -2.87%61 ROE % is 11.76% as of Dec. 2025, which is 45% above its 10-year median of 8.12. GuruFocus rates MPFRF with a GF Score™ of 61/100 and a GF Value™ of $2.62 (Significantly Overvalued). The stock has 5 warning signs investors should review. Among 504 Insurance companies, Mapfre ranks better than 52.98% on this metric.
ROE % is calculated as Net Income divided by its average Total Stockholders Equity over a certain period of time. Mapfre's annualized net income for the quarter that ended in Dec. 2025 was $1,257 Mil. Mapfre's average Total Stockholders Equity over the quarter that ended in Dec. 2025 was $10,692 Mil. Therefore, Mapfre's annualized ROE % for the quarter that ended in Dec. 2025 was 11.76%.
The historical rank and industry rank for Mapfre's ROE % or its related term are showing as below:
MPFRF'
s ROE % Range Over the Past 10 Years
Min: 6.06 Med: 8.12 Max: 12.45
Current: 12.45
During the past 13 years, Mapfre's highest ROE % was 12.45%. The lowest was 6.06%. And the median was 8.12%.
MPFRF's ROE % is ranked better than 52.98% of 504
companies
in the Insurance industry
Industry Median: 11.675
vs MPFRF: 12.45
Mapfre (OTCPK:MPFRF) ROE % Explanation
ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.
The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:
Note:
The net income data used here is two times the semi-annual (Dec. 2025) net income data. The Revenue data used here is two times the semi-annual (Dec. 2025) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Net Income is used.
Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.
Mapfre ROE % Related Terms
Mapfre ROE % Historical Data
* Premium members only.
The historical data trend for Mapfre's ROE % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Insurance - Diversified subindustry, Mapfre's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Mapfre ROE % vs Insurance Industry
For the Insurance industry and Financial Services sector, Mapfre's ROE % distribution charts can be found below:
* The bar in red indicates where Mapfre's ROE % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is two times the semi-annual (Dec. 2025) net income data.
ROE % is displayed in the 30-year financial page.
Mapfre (MPFRF) has a ROE % of 11.76% as of Dec. 2025. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Mapfre and its competitors. This is 45% above median its historical median of 8.12. Over the past decade, Mapfre's ROE % has ranged from 6.06 to 12.45. According to the industry distribution chart, Mapfre ranks #237 out of 504 companies in the Insurance industry, placing it in the top 47%.
Is Mapfre's ROE % too high?
Mapfre's current ROE % of 11.76% is 45% above median its 10-year median of 8.12. Over the past 10 years, this metric has ranged from a low of 6.06 to a high of 12.45. The Insurance industry median ROE % is 11.68. Mapfre's value of 11.76% is 0.7% above this industry median. Based on the distribution chart, Mapfre ranks #237 out of 504 companies in the Insurance industry, which is above the industry midpoint. Overall, Mapfre has a GF Score™ of 61/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Mapfre's ROE % compare to BRK.A and AIG?
According to the Insurance industry distribution chart, Mapfre ranks #237 out of 504 companies for ROE %. This puts Mapfre in the upper half of its industry. The industry median ROE % is 11.68. Mapfre's value of 11.76% is 0.7% above this benchmark. Historically, Mapfre's own ROE % has ranged from 6.06 to 12.45 over the past decade. While the company's 10-year median is 8.12 vs. the industry median of 11.68, Mapfre has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % for an Insurance company?
The median ROE % among Insurance companies is 11.68, based on 504 companies in the industry. Companies in the top quartile (top 25%) have a ROE % significantly above this median, while those in the bottom quartile fall well below. However, ROE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Mapfre's current ROE % of 11.76% is 0.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % mean?
A high ROE % can signal that a stock is expensive relative to its fundamentals. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Mapfre and its competitors. For the Insurance industry, the median ROE % is 11.68 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Mapfre's current ROE % is 11.76%, which is 45% above median its own 10-year median of 8.12. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Mapfre stock overvalued right now?
Based on GuruFocus' analysis, Mapfre (MPFRF) is currently considered Significantly Overvalued. The stock's GF Value™ is $2.62, compared to a current price of $4.86 — trading 85.4% above its estimated fair value. The current ROE % is 11.76%, which is 45% above median its 10-year median of 8.12 and 0.7% above the Insurance industry median of 11.68. Mapfre's overall GF Score™ is 61/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % calculated?
ROE % is calculated from a company's financial statements. For Mapfre (MPFRF), the current ROE % is 11.76% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Mapfre (MPFRF) Overvalued in 2026?
Based on GuruFocus' analysis, Mapfre stock appears to be overvalued.
The current stock price of $4.86 is trading 85.4% above its estimated GF Value™ of $2.62.
GuruFocus considers Mapfre to be Significantly Overvalued.
Key valuation signals for MPFRF:
ROE %: 11.76% (45% above median its 10-year median of 8.12)
GF Value™: $2.62 vs. price of $4.86 (85.4% above fair value)
Industry Position: 0.7% above the Insurance median (#237 of 504)
No single metric tells the full story. See the MPFRF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Mapfre SA engaged in insurance activity in its various lines of business, both life and non-life, finance, securities investment, and services. It has Insurance business units in Iberia, Brazil, Latam north, Latam south, North America and Eurasia also Assistance unit, Global risks unit and Reinsurance unit around the world. Key revenue comes from Iberia. Mapfre also provides health and other non-life insurance policies.
61GF Score
Get the complete analysis for MPFRF
ROE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MPFRF has been successfully added to your 
